The treatment of Bronchitis & Spinal Arthritis with vitamins

Bronchitis and Spinal Arthritis: Mitamins custom make quality formulas for the treatment of Bronchitis & Spinal Arthritis with vitamins. A Bronchitis & Spinal Arthritis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Bronchitis and Spinal Arthritis

  • Amount Per Serving
    % DV
    Vitamin C
    50
    mg
    83%
    Potassium
    100
    mg
    3%
    CoQ-10
    25
    mg
    *
    Omega - 3 Fatty Acids
    100
    mg
    *
    Chondroitin Sulfate
    200
    mg
    *
    Astragalus Extract
    50
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
    Feverfew Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
  • Amount Per Serving
    % DV
    American Ginseng Extract
    100
    mg
    *
    Green Tea Extract
    50
    mg
    *
    Licorice Extract
    250
    mg
    *
    Quercetin
    100
    mg
    *
    L-Glutamine
    100
    mg
    *
    Ginger Extract
    100
    mg
    *
    White Willow Extract
    60
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Bronchitis and Spinal Arthritis
Serving Size:4-5

Bronchitis and Spinal Arthritis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Nebivolol Lowers Blood Pressure In Mild-To-Moderate Hypertensive Patients AS Demonstrated In A Study Published In The Journal Of Clinical Hypertension
Forest Laboratories, Inc. (NYSE: FRX) announced the results of a controlled clinical trial, published in the September 2007 issue of the Journal of Clinical Hypertension, which demonstrated that nebivolol, a selective beta 1-blocker with vasodilating properties, significantly reduced sitting diastolic and systolic blood pressure among patients with mild-to-moderate hypertension. The study - the first to evaluate the drug in a U.S.
Nebivolol Lowers Blood Pressure In Mild To Moderate Hypertensive Patients As Demonstrated In A Study Published In The Journal Of Clinical Hypertension
Forest Laboratories, Inc. (NYSE: FRX) announced the results of a controlled clinical trial, published in the September 2007 issue of the Journal of Clinical Hypertension, which demonstrated that nebivolol, a selective beta 1-blocker with vasodilating properties, significantly reduced sitting diastolic and systolic blood pressure among patients with mild-to-moderate hypertension. The study the first to evaluate the drug in a U.S.
This information concerning the support of Bronchitis and Spinal Arthritis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments